Clinical Trials Logo

Filter by:
NCT ID: NCT00114504 Completed - Atherosclerosis Clinical Trials

Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation

Start date: September 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether FDG-PET is capable of detecting atherosclerotic plaque inflammation and monitoring the effects of statins on plaque inflammation. The usefulness of FDG-PET in risk stratification is also investigated.

NCT ID: NCT00112489 Completed - Sarcoma Clinical Trials

Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer

Start date: May 2005
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving paclitaxel together with carboplatin works in treating patients with persistent or recurrent stage III or stage IV uterine cancer.

NCT ID: NCT00112099 Completed - Gastric Neoplasm Clinical Trials

GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110

Start date: June 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the role of splenectomy in potentially curative total gastrectomy for proximal gastric carcinoma in terms of survival benefit and post-operative morbidity.

NCT ID: NCT00112086 Completed - Ovarian Neoplasms Clinical Trials

OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206

Start date: January 2003
Phase: Phase 2
Study type: Interventional

A feasibility study of neoadjuvant chemotherapy (NAC) followed by interval cytoreductive surgery (ICS) and postoperative chemotherapy for stage III/IV mullerian carcinomas such as ovarian, tubal and peritoneal carcinomas.

NCT ID: NCT00110448 Completed - Clinical trials for Diabetes Mellitus, Type 2

Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial

Start date: December 2002
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the effects of low-dose aspirin for the primary prevention of vascular events in patients with type 2 diabetes in Japan.

NCT ID: NCT00107393 Completed - Breast Cancer Clinical Trials

Trastuzumab and Capecitabine in Treating Women With Metastatic Breast Cancer

Start date: June 2003
Phase: Phase 2
Study type: Interventional

RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Drugs used in chemotherapy, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving trastuzumab together with capecitabine may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving trastuzumab together with capecitabine works in treating women with metastatic breast cancer.

NCT ID: NCT00106236 Completed - Hypertension Clinical Trials

Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction

Start date: April 2003
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of the study is to determine whether exercise has further beneficial effects on improving cardiovascular risk factors such as hypertension, high cholesterol level or diabetes mellitus, when added to the standard program of health check followed by life style recommendations.

NCT ID: NCT00106158 Completed - Neoplasms Clinical Trials

Safety Study of NY-ESO-1 Protein Vaccine to Treat Cancer Expressing NY-ESO-1

Start date: June 2004
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety of repeated doses of cholesterol-bearing hydrophobized pullulan (CHP) and NY-ESO-1 protein (CHP-NY-ESO-1) and describe the NY-ESO-1 specific-humoral and cellular immune response to immunization with CHP-NY-ESO-1 in patients with cancer expressing NY-ESO-1.

NCT ID: NCT00104793 Completed - Lung Cancer Clinical Trials

Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer

Start date: June 2003
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as irinotecan and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving irinotecan together with carboplatin may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving irinotecan together with carboplatin works in treating patients with newly diagnosed extensive-stage small cell lung cancer.

NCT ID: NCT00101699 Completed - Menopause Clinical Trials

Effects of Soy Consumption on Symptoms of Menopause

Start date: November 2001
Phase: N/A
Study type: Observational

The purpose of this study is to examine the way soy consumption affects menopausal symptoms in middle-aged Japanese women.